Nothing Special   »   [go: up one dir, main page]

DK573587A - Fremgangsmaade til fremstilling af en faktor viii (ahf)-holdig fraktion - Google Patents

Fremgangsmaade til fremstilling af en faktor viii (ahf)-holdig fraktion

Info

Publication number
DK573587A
DK573587A DK573587A DK573587A DK573587A DK 573587 A DK573587 A DK 573587A DK 573587 A DK573587 A DK 573587A DK 573587 A DK573587 A DK 573587A DK 573587 A DK573587 A DK 573587A
Authority
DK
Denmark
Prior art keywords
factor viii
ahf
preparing
procedure
containing fraction
Prior art date
Application number
DK573587A
Other languages
English (en)
Other versions
DK573587D0 (da
Inventor
Otto Schwarz
Yendra Linnau
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of DK573587D0 publication Critical patent/DK573587D0/da
Publication of DK573587A publication Critical patent/DK573587A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK573587A 1986-11-03 1987-11-02 Fremgangsmaade til fremstilling af en faktor viii (ahf)-holdig fraktion DK573587A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0292386A AT391808B (de) 1986-11-03 1986-11-03 Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion

Publications (2)

Publication Number Publication Date
DK573587D0 DK573587D0 (da) 1987-11-02
DK573587A true DK573587A (da) 1988-05-04

Family

ID=3542434

Family Applications (1)

Application Number Title Priority Date Filing Date
DK573587A DK573587A (da) 1986-11-03 1987-11-02 Fremgangsmaade til fremstilling af en faktor viii (ahf)-holdig fraktion

Country Status (8)

Country Link
US (1) US4814435A (da)
EP (1) EP0270516B1 (da)
JP (1) JPH0730117B2 (da)
AT (2) AT391808B (da)
CA (1) CA1297011C (da)
DE (1) DE3769096D1 (da)
DK (1) DK573587A (da)
ES (1) ES2028913T3 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005220A1 (en) * 1986-03-10 1987-09-11 Rubinstein Alan I A method for treating gammaglobulin
DK162233C (da) * 1989-11-09 1992-03-16 Novo Nordisk As Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
AU6653094A (en) * 1992-12-16 1994-07-04 Immuno Aktiengesellschaft Process for preparing a virus-safe biological composition
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
AT404358B (de) 1997-02-04 1998-11-25 Immuno Ag Verfahren zur chromatographischen reinigung bzw. fraktionierung von von willebrand-faktor aus einem vwf-hältigen ausgangsmaterial
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
PL203177B1 (pl) 1999-02-22 2009-09-30 Baxter Int Sposób liofilizacji wodnego preparatu farmaceutycznego
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
AT501088A2 (de) * 2002-12-18 2006-06-15 Bio Prod & Bio Eng Ag Stabile therapeutische proteine
US20060223988A1 (en) * 2005-04-05 2006-10-05 National Research Laboratories, Ltd. High Resolution Methods and Precipitating Reagents for Isolating Proteins from Proteinaceous Material
BRPI0921429B1 (pt) 2008-11-07 2022-07-12 Takeda Pharmaceutical Company Limited Formulação farmacêutica liofilizada estável, e, método para preparar um fator liofilizado estável
JP6583766B2 (ja) * 2015-02-02 2019-10-02 学校法人北里研究所 タンパク質分離方法、タンパク質分析方法、及びタンパク質分離キット
US10815270B1 (en) * 2019-09-20 2020-10-27 Plasma Technologies, Llc Compositions and methods for high efficiency protein precipitation

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022758A (en) * 1973-06-19 1977-05-10 Ab Kabi Isolation of coagulation factors I and VIII from biological material
US3973002A (en) * 1974-04-12 1976-08-03 E. R. Squibb & Sons, Inc. Antihemophilic factor
US4188318A (en) * 1975-06-16 1980-02-12 Edward Shanbrom Simplified method for preparation of high yield, high purity Factor VIII concentrate
JPS52125609A (en) * 1976-04-09 1977-10-21 Green Cross Corp:The Purification of agglutination factor viii
CA1054052A (en) * 1976-08-14 1979-05-08 Edward Shanbrom Simplified method for preparation of high yield, high purity factor viii concentrate
US4104266A (en) * 1977-04-14 1978-08-01 American National Red Cross Method for preparation of antihemophilic factor
US4170639A (en) * 1978-07-10 1979-10-09 Warner-Lambert Company Antihemophilic factor concentrate and its production
AT359646B (de) * 1979-04-19 1980-11-25 Immuno Ag Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4305871A (en) * 1980-09-02 1981-12-15 Edward Shanbrom Method of selectively increasing yield and purity of certain cryoprecipitate proteins by heating
WO1982004395A1 (en) * 1981-06-18 1982-12-23 Erik Gustaf Birger Blombaeck A process in purification and concentration of the factor viii complex
US4456590B2 (en) * 1981-11-02 1989-05-30 Heat treatment of lyphilized blood clotting factor viii concentrate
US4495175A (en) * 1982-08-05 1985-01-22 University Of Rochester Preparation of highly purified human antihemophilic factor
CA1207662A (en) * 1982-12-02 1986-07-15 Ricardo H. Landaburu Hepatitis b and non-a-non-b-safe biological products
AT376884B (de) * 1983-05-02 1985-01-10 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen krankeitserregern
EP0124506B1 (de) * 1983-05-02 1988-08-17 IMMUNO Aktiengesellschaft für chemisch-medizinische Produkte Verfahren zur Inaktivierung von vermehrungsfähigen Krankheitserregern
AT379310B (de) * 1983-05-20 1985-12-27 Immuno Ag Verfahren zur herstellung eines antithrombin iii-heparin- bzw. antithrombin iii-heparinoidkonzentrates
DE3318521A1 (de) * 1983-05-20 1984-11-22 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung eines antihaemophiliefaktor-konzentrats
AT379510B (de) * 1983-05-20 1986-01-27 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf) -haeltigen praeparation
US4486410A (en) * 1984-02-09 1984-12-04 Armour Pharmaceutical Company Heat defibrinogenation of AHF preparation
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii

Also Published As

Publication number Publication date
CA1297011C (en) 1992-03-10
EP0270516B1 (de) 1991-04-03
US4814435A (en) 1989-03-21
ATA292386A (de) 1990-06-15
DK573587D0 (da) 1987-11-02
DE3769096D1 (de) 1991-05-08
ES2028913T3 (es) 1992-07-16
EP0270516A3 (en) 1988-06-22
EP0270516A2 (de) 1988-06-08
ATE62133T1 (de) 1991-04-15
AT391808B (de) 1990-12-10
JPS63132899A (ja) 1988-06-04
JPH0730117B2 (ja) 1995-04-05

Similar Documents

Publication Publication Date Title
DK573587A (da) Fremgangsmaade til fremstilling af en faktor viii (ahf)-holdig fraktion
NO177188C (no) Fremgangsmåte for separering av humane eller animalske plasmaproteiner
HUP9900920A2 (hu) Eljárás emlőssejt-tenyészetekben termelt proteinek szializációjának szabályozására
ATE294864T1 (de) Äusseres membranprotein von haemophilus
DK0429570T3 (da) Osteoinducerende præparater
PT91170A (pt) Processo de preparacao de um preparado de imunoglobulina policlonal com elevado teor de igm
ATE316571T1 (de) Purifikation von viruspräparaten
DK450785A (da) Fremgangsmaade til fremstilling af et koncentrat af antihaemofilisk faktor med hoej renhed
DK158281C (da) Fremgangsmaade til fremstilling af et faktor viii (ahf)-holdigt praeparat
SE8104482L (sv) Forfarande for framstellning av ett faktor viii (ahf)-hogkoncentrat
DE3872137D1 (de) Verfahren zur herstellung eines hochreinen, virussicheren, biologisch aktiven transferrinpraeparates.
ES8503238A1 (es) Procedimiento de preparar concentrados y nutrimentos proteinicos
ATE111480T1 (de) Verfahren zur rückgewinnung rekombinanter proteine unter verwendung von flockungsmitteln.
UA13377A (uk) Спосіб одержаhhя противірусhого засобу
ATA901196A (de) Verwendung von aktiviertem protein c zur herstellung einer pharmazeutischen präparation
Stewart et al. Interferoids: In vitro and in vivo conversion of native interferons to lower molecular weight forms
JPS57193494A (en) Method of purifying or concentrating biologically active protein and drug therefor
EP0552257A4 (en) A plant protein useful for treating tumors and hiv infection
DE3479032D1 (en) Process for preparing an antihaemophilic factor concentrate
EP0449897B1 (en) A pure factor i protein and a process for producing said protein
ATE13633T1 (de) Verfahren zur herstellung von hochgereinigtem antihaemophiliefaktor.
KR970042593A (ko) 재조합 알파-인터페론의 정제방법
JPS61207334A (ja) 腫瘍細胞障害性物質
RU93005154A (ru) Белки, фармацевтические композиции, нуклеиновые кислоты, векторы, системы вектор-хозяин, способ получения белка, способы модифицирования функции, способы лечения, способ трансфекции, способ переноса гена, способ измерения активности

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment